SGLT1 expression increased in patients with diabetes cardiomyopathy and in streptozotocin diabetes rats; inhibiting SGLT1 attenuates apoptosis and inhibits the development of diabetes cardiomyopathy. This evidence concerns the gene SLC5A1 and diabetic cardiomyopathy.